Skip to content

Clinical trials

Phase 2 Hypoparathyroidism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoparathyroidism Phase: Phase 2 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20082
20101
20142
20171
20181
20191
20231
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting2
Recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Entera Bio Ltd.2
MBX Biosciences2
Amorphical Ltd.1
Ascendis Pharma A/S1
Assistance Publique - Hôpitaux de Paris1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Extend Biosciences Inc.1
Mayo Clinic1
National Institute of Dental and Craniofacial Research (NIDCR)1
National Institutes of Health Clinical Center (CC)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoparathyroidism17
Hypocalcemia6
Thyroid Diseases2
DiGeorge Syndrome1
Dysphonia1
Endocrine System Diseases1
Hoarseness1
Hypercalciuria1
Immunologic Deficiency Syndromes1
Parathyroid Diseases1

Trials

Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.